Dual-target antibody targeting VEGFR-2 and DLL4 and pharmaceutical composition including same

The present invention relates to a novel form of a dual-target antibody targeting VEGFR-2 and DLL4, a gene encoding the same, a recombinant expression vector including the gene, host cells transformed with the recombinant expression vector, a method of producing the dual-target antibody using the ho...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Choi, Jin Hee, Lee, Young Ae, Kim, Joong Kyu, Jeong, Jong Geun, Nahm, Kyung Hee, Park, Mi Ju, Yoon, Jae Bong, Kim, Do Yun, Kim, Sung Woo, Yoo, Jin San, Oh, Seon Hwan, Shim, Sang Ryeol, Jeong, Bo Young, Park, In Sook, Nam, Ju Ryung, Lee, Seon Young, Lee, Eun Jin, Lee, Hyuk Joon, Kim, Yeun Ju, Lee, Jin Sook, Byun, Sang Soon, Kim, Nam Ye, Yoo, Jin Sang, Lee, Weon Sup, Lee, Sang Hoon
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to a novel form of a dual-target antibody targeting VEGFR-2 and DLL4, a gene encoding the same, a recombinant expression vector including the gene, host cells transformed with the recombinant expression vector, a method of producing the dual-target antibody using the host cells, a pharmaceutical composition comprising the dual-target antibody.